← Back

Shanghai Orient-Chip Technology Co. Ltd. A

Shanghai Orient-Chip Technology Co., Ltd. researches, develops, designs, and produces mixed-signal and analog integrated circuits. Its products include magnetic sensors, power management chips, motor drives, and optoelectronic sensors. These are used in consumer electronics, automated industry, automotive, and energy and infrastructure applications. The company was founded in 2005 and is headquartered in Shanghai, China.

Price · split & dividend adjusted
News & notes moving 688061.CG
China
688061.CG

Canrui Technology first-half revenue 308 million yuan, loss narrows to 24.06 million yuan

Canrui Technology released its 2026 half-year report. Operating revenue was 308 million yuan, up 4.8 percent year on year. Net profit attributable to the parent company narrowed from a loss of 26.82 million yuan in the same period last year to a loss of 24.06 million yuan. Second-quarter operating revenue was 176 million yuan, up 4.8 percent year on year, while the net loss attributable to the parent company was 3.06 million yuan, a significant narrowing from a loss of 13.34 million yuan a year earlier. Revenue from the smart sensor business reached 183 million yuan, and power management chip revenue was 95.39 million yuan, up 2.56 percent and 13.31 percent respectively from the same period last year. As of the end of the second quarter, total assets were 2.653 billion yuan, down 2.7 percent from the end of the previous year, and net assets attributable to the parent company were 2.252 billion yuan, down 4.0 percent from the end of the previous year.
688061.CG · Capital · Neutral Company reports narrower loss and slight revenue growth, but still loss-making.
Read original ↗
财中社·42dRead more →
Biotech & Genomic Medicine▲

STAR Market Evening Report: Dongxin Shares Expects Niche Memory Prices to Rise in Second Half; JPT to Acquire All Shares of NEOPTICS

Dongxin Shares indicated that the price increase trend for niche memory products continued in the second quarter, and prices are expected to keep rising in the second half of the year. JPT plans to acquire 100% equity in NEOPTICS for 1.12 million Singapore dollars through a wholly owned subsidiary, aiming to strengthen its optical connectivity business. South Korea, together with companies like Samsung and SK, has launched a 312 trillion won investment plan, focusing on the semiconductor and aerospace industries. The National Medical Products Administration plans to include eligible cell and gene therapy drugs in the 30-day review and approval channel for innovative drug clinical trials. Alibaba has completely banned internal use of Claude Code starting July 10 due to the risk of implanted backdoors. This week, the Shanghai Stock Exchange conducted focused monitoring of stocks with abnormal fluctuations such as CSSC Special Gas, Changyingtong, and Yunzhong Technology, as well as funds with high premiums like Caitong Fuxin LOF and Global Chip LOF. Deutsche Bank estimates that Meta's cloud business could generate additional revenue of 9 billion to 30 billion US dollars by 2027. Huaqin Technology signed a framework sales contract for special functional materials for aircraft fuselages worth approximately 278 million yuan. Sun-Novo plans to raise no more than 240 million yuan for nucleic acid drug platform construction. Rushen Robotics and InnoMab completed Pre-A round financing of 100 million yuan and several hundred million yuan, respectively.
About megatrends
Biotech & Genomic Medicine › Cell Therapy (CAR-T & beyond) ▲Regulation
Biotech & Genomic Medicine › RNA Therapeutics ▲Capital
Semiconductors › Memory — DRAM, NAND & HBM ▲Pricing
688025.CG · Capital · Positive JPT plans to acquire 100% equity of NEOPTICS for 1.12 million SGD to strengthen optical connectivity business.
688110.CG · Pricing · Positive Dongxin Shares (Dosilicon) indicated niche memory prices expected to keep rising in second half, benefiting pricing power.
688110.CG · Demand · Positive Dongxin Shares indicated niche memory prices are expected to keep rising in second half.
688281.CG · Demand · Positive Signed a framework sales contract for special functional materials for aircraft fuselages worth ~278 million yuan
688621.CG · Capital · Positive Sun-Novo plans to raise up to 240 million yuan for nucleic acid drug platform construction.
Rushen Robotics · Capital · Positive Rushen Robotics completed Pre-A round financing of 100 million yuan.
Read original ↗